Cancer Research UK has announced the appointment of two new trustees to its Council: Michael Pragnell and Professor Anton Berns.
Michael Pragnell is expected to succeed David Newbigging as chairman of Cancer Research UK in November.
He was the founder chief executive Officer of Syngenta AG, a company in crop protection and plant bioscience, and was formerly CEO of AstraZeneca plc's crop protection business.
Professor Anton Berns is the director of Research at The Netherlands Cancer Institute and Professor of Experimental Genetics of Inherited Diseases at the University of Amsterdam.
David Newbigging, chairman of Cancer Research UK, said: "We're delighted to welcome Michael Pragnell and Professor Berns to our Council. Michael joins our Council after an outstandingly successful career as Chief Executive of Syngenta, prior to which he was with AstraZeneca and before that Courtaulds. In addition, he has considerable international experience having worked in the US and Continental Europe as well as in the UK.
Latest News
-
Nine in ten charities using AI but few exploring its ‘true potential’, warns research
-
Evaluation reveals benefits of adding a virtual candle to online fundraising
-
Former Scope CEO to chair business group set up to tackle disability exclusion
-
Senior MP’s comparison of charity retail with vape shops criticised as 'outdated'
-
Working Families closes following ‘a sustained period of financial challenge’
-
Case study: How charities can best protect their storytellers
Charity Times video Q&A: In conversation with Hilda Hayo, CEO of Dementia UK
Charity Times editor, Lauren Weymouth, is joined by Dementia UK CEO, Hilda Hayo to discuss why the charity receives such high workplace satisfaction results, what a positive working culture looks like and the importance of lived experience among staff. The pair talk about challenges facing the charity, the impact felt by the pandemic and how it's striving to overcome obstacles and continue to be a highly impactful organisation for anybody affected by dementia.
Charity Times Awards 2023
Mitigating risk and reducing claims
The cost-of-living crisis is impacting charities in a number of ways, including the risks they take. Endsleigh Insurance’s* senior risk management consultant Scott Crichton joins Charity Times to discuss the ramifications of prioritising certain types of risk over others, the financial implications risk can have if not managed properly, and tips for charities to help manage those risks.
* Coming soon… Howden, the new name for Endsleigh.
* Coming soon… Howden, the new name for Endsleigh.
Better Society
© 2021 Perspective Publishing Privacy & Cookies
Recent Stories